Back to search

Michigan State University

Mechanisms of 5-hydroxytryptamine-induced hypotension

Abstract

dc:description

Chronic serotonin (5-hydroxytryptamine, 5-HT) infusion results in a sustained fall in blood pressure in the sham and deoxycorticosterone acetate (DOCA)-salt rat. The exact mechanism(s) underlying a 5-HT-induced fall in blood pressure are not yet known. We hypothesize that 5-HT lowers blood pressure in a nitric oxide (NO)-dependent manner by reducing total peripheral resistance (TPR), either through a reduction in sympathetic nervous system (SNS) tone and/or direct stimulation of vascular 5-HT receptors. 5-HT (25 μg/kg/min; s.c.) or vehicle was infused to male Sprague Dawley or DOCA-salt hypertensive rats. Mean arterial pressure (MAP) was measured via radiotelemetry. Cardiac output (CO) was measured via aortic flow probes. 5-HT produced a significant reduction in MAP, increase in cardiac output (CO) and stroke volume (SV), and a significant reduction in total peripheral resistance (TPR). Additionally, 5-HT produced a sustained (one-month) fall in blood pressure in the DOCA-salt rat, but did not prevent the development of DOCA-salt hypertension. Isometric contractile force was measured in the sham and DOCA-salt superior mesenteric artery (SMA) to determine whether direct 5-HT receptor activtation was capable of relaxing the SMA. BW 723C86 (5-HT2B), CP 93129 (5-HT1B), and LP-44 (5-HT7) did not relax the SMA from sham or DOCA-salt rats vs. vehicle. Electrical field stimulation (EFS) was used to determine whether 5-HT was acting to inhibit neurogenic contraction in the isolated SMA. EFS-induced contraction was not significantly different in 5-HT incuabted vs. vehicle incuabted SMA under several conditions. Finally, several studies implicate the importance of the serotonin transporter (SERT) in mediating the effects of 5-HT. 5-HT produced a significantly greater fall in MAP in the SERT WT rat vs. the SERT KO rats suggesting a potentially important role for SERT in producing a 5-HT-induced fall in blood pressure. This research fills a gap in our understanding of how 5-HT functions in the cardiovascular system and validates our hypothesis that 5-HT lowers blood pressure through a reduction in total peripherl resistance. However, this research suggests that 5-HT is not acting through direct receptor mediated vascular relxation or through inhibition of NE release at the nerve terminal in the superior mesenteric artery to lower blood pressure.

Author and committee

dc:creator, dc:contributor.*
Author dc:creator
  • Davis, Robert Patrick
Contributors dc:contributor
  • Watts, Stephanie W.
  • Fink, Gregory
  • Dorrance, Anne
  • Crockett, Elahe

Subjects

dc:subject × 2

Rights

dc:rights
Statement dc:rights
  • In Copyright
Language dc:language
English

Identifiers

dc:identifier.*
Identifier
etd:2010
isbn:9781124718552
isbn:1124718559
oclc:931842734
umi:3460272
local:Davis_grad.msu_0128D_10467

Chain of custody

source
Harvested from
Michigan State University
Base URL
d.lib.msu.edu/oai
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Davis, Robert Patrick. Mechanisms of 5-hydroxytryptamine-induced hypotension. 2011. https://doi.org/doi:10.25335/5122-j009